LiaX is a Surrogate Marker For Cell Envelope Stress and Daptomycin Non-Susceptibility in Enterococcus Faecium

Authors

Dierdre B Axell-House
Shelby R Simar
Diana Panesso
Sandra Rincon
William R Miller
Ayesha Khan
Orville A Pemberton
Lizbet Valdez
April H Nguyen
Kara S Hood
Kirsten Rydell
Andrea M DeTranaltes
Mary N Jones
Rachel Atterstrom
Jinnethe Reyes
Pranoti V Sahasrabhojane
Geehan Suleyman
Marcus Zervos
Samuel A Shelburne
Kavindra V Singh
Yousif Shamoo
Blake M Hanson
Truc T Tran
Cesar A Arias

Language

English

Publication Date

3-6-2024

Journal

Antimicrobial Agents and Chemotherapy

DOI

10.1128/aac.01069-23

PMID

38289081

PMCID

PMC10916372

PubMedCentral® Posted Date

January 2024

PubMedCentral® Full Text Version

Post-print

Abstract

Daptomycin (DAP) is often used as a first-line therapy to treat vancomycin-resistant

Keywords

Humans, Daptomycin, Enterococcus faecium, Phylogeny, Reproducibility of Results, Drug Resistance, Bacterial, Anti-Bacterial Agents, Cell Membrane, Biomarkers, Microbial Sensitivity Tests, Enterococcus faecalis, Gram-Positive Bacterial Infections

Recommended Citation

Axell-House, Dierdre B; Simar, Shelby R; Panesso, Diana; et al., "LiaX is a Surrogate Marker For Cell Envelope Stress and Daptomycin Non-Susceptibility in Enterococcus Faecium" (2024). Faculty, Staff and Student Publications. 324.
https://digitalcommons.library.tmc.edu/uthsph_docs/324